Congress presentation: ISGE 2026 Consistency in effect of elinzanetant on wakefulness after sleep onset across subjective and objective measures: post hoc analysis of the Phase II NIRVANA pilot study

Bayer AG 2026 Open access

Read full text
Authors: Claudio N. Soares, Gary K Zammit, Rossella Elena Nappi, Fiona Baker, Hadine Joffe, Pauline M. Maki, Cecilia Caetano, Hoi-Shen Radcliffe, Ulrike Krahn, Huda Shalhoub, Frank Kramer, Christian Seitz
DOI: 10.71943/bayer.figshare.31211182
Cited by: 0

Abstract

This post hoc analysis evaluated whether changes in wakefulness after sleep onset (WASO) with elinzanetant were observed across objective (polysomnography, Sleepiz One+) and subjective measures (Sleep Diary) in postmenopausal women with moderate-to-severe vasomotor symptoms. Greater numerical reductions in WASO were seen in the elinzanetant arm compared with placebo across all measurements.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Sleep and related disorders Sleep and Wakefulness Research

Publication details

Journal / source
Bayer AG
Publication date
5 March 2026
Language
EN